Seres Therapeutics, Inc.MCRBNASDAQ
Loading
Year-over-year total asset growth rate
Percentile
P64
Within normal range
vs 3Y Ago
-0.3x
Contraction
Streak
1 qtr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| Q4 2025 | -3.68% |
| Q3 2025 | -0.23% |
| Q2 2025 | -12.41% |
| Q1 2025 | 17.43% |
| Q4 2024 | -21.78% |
| Q3 2024 | -44.44% |
| Q2 2024 | -5.72% |
| Q1 2024 | -4.83% |
| Q4 2023 | -2.47% |
| Q3 2023 | -9.52% |
| Q2 2023 | 50.41% |
| Q1 2023 | -22.53% |
| Q4 2022 | 11.84% |
| Q3 2022 | 14.16% |
| Q2 2022 | -14.60% |
| Q1 2022 | -9.85% |
| Q4 2021 | -10.46% |
| Q3 2021 | 46.97% |
| Q2 2021 | -11.79% |
| Q1 2021 | -10.86% |
| Q4 2020 | -3.72% |
| Q3 2020 | 253.80% |
| Q2 2020 | -8.99% |
| Q1 2020 | -16.48% |
| Q4 2019 | 6.68% |
| Q3 2019 | -15.02% |
| Q2 2019 | 36.48% |
| Q1 2019 | -11.15% |
| Q4 2018 | 10.48% |
| Q3 2018 | -17.99% |
| Q2 2018 | -16.61% |
| Q1 2018 | -15.88% |
| Q4 2017 | -10.55% |
| Q3 2017 | -2.06% |
| Q2 2017 | -11.64% |
| Q1 2017 | -10.19% |
| Q4 2016 | -8.36% |
| Q3 2016 | -2.84% |
| Q2 2016 | -5.62% |
| Q1 2016 | 49.59% |